Pharmaceuticals

Biotech stocks are often one of the first subsectors to bounce in a bear market and/or harsh selloff; this is the case because the overall valuation of these companies is based off of market independent actions. Shares of biotechs that are liquidated in a harsh sell off are typically done for...

Shares of Amarin (NASDAQ: AMRN) are higher on the session by 8.64%, currently trading at $13.20. The stock has been moving largely higher over the past few days and is currently testing the 50-day moving average. Options traders are buying calls on the name today. A short while ago the September...

Shares of Mylan (NYSE: MYL) are higher on the session by 2.13%, currently trading at $19.19. The stock has been moving largely lower over the past five weeks and is currently trading below the 50-day moving average. Options traders are buying calls on the name today. A short while ago the January...

Life Tech Capital reiterated its Strong Buy on Oculus Innovative Sciences (NASDAQ: OCLS). At the same time, the rating agency left its price target on the company's stock unchanged at $4.75. On Thursday, OCLS added 5.38% to its value to finish the day at $1.37.

This is your Benzinga news summary and traders' outlook for Friday, August 12, 2011, covering headlines from overnight and Friday's pre-market session. Today in domestic pre-market trading, U.S. equity futures are trading flat after a 400 point rally in the Dow yesterday. At last check, Dow...

A Peek Into The Market Before The Trading Starts Pre-open movers US stock futures are flat this morning, as investors are awaiting economic data. Futures for the Dow Jones Industrial Average surged 10 points to 11,094.00 and S&P 500 index futures rose 0.90 points to 1,169.40. Nasdaq 100 futures...

Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Alfuzosin Hydrochloride Extended-release Tablets, 10 mg. This product is the generic version of Uroxatral®, a treatment for signs and symptoms of benign prostatic hyperplasia, or an enlarged prostate...

The French economy unexpectedly stagnated during the 2nd quarter, according to France's National Institute of Statistics and Economic Studies, which reported that France's 2nd quarter economic growth rate was 0% and that consumer spending fell 0.9%. The news is troubling because France is the...

Merlin Nexus and New Leaf Venture Partners (NLV Partners), stockholders in Icagen, Inc. (Nasdaq: ICGN), submitted a second letter to the Icagen Board contesting the company's planned acquisition by Pfizer Inc (NYSE: PFE). According to a July 20, 2011 press announcement, Pfizer plans to purchase the...

Citi is maintaining its Buy rating and its $82 price target on Watson Pharmaceuticals (NYSE: WPI) in light of expected margin expansion from the company. Says Citi, in its report, “We project Concerta sales of $132M/$156M in 3Q11/4Q11 & Lipitor sales of $345M in 4Q11 (Nov. '11 launch) to fuel...

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that it has filed lawsuits in the U.S. District Court for the District of Delaware against Par Pharmaceutical, Inc. (NYSE: PRX) and Par Pharmaceutical Companies, Inc and Actavis South Atlantic LLC and Actavis, Inc.. The lawsuits were...

Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced shipping of its Morphine Sulfate Oral Solution product. The company received approval from the U.S. Food and Drug Administration for its 505(b)(2) New Drug Application (NDA) on June 23, 2011. Sales of Morphine Sulfate Oral...

MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the United States Patent and Trademark Office issued to the Company U.S. Patent No. 7,994,197, titled "Method of Therapeutic Administration of DHE to Enable Rapid Relief of Migraine while Minimizing Side Effect Profile." The patent,...

On CNBC's Mad Money, Jim Cramer said during the Lightning Round that Cummins (NYSE: CMI) is an “unbelievable manufacturer with a big backlog. I think you should buy some more at these levels." Cramer said that he has “disliked Merck (NYSE: MRK), but it yields 5% and I'm changing my tune. I'm a...

There's certainly no shortage of pundits, prognosticators and even self-proclaimed prophets ready and willing to bombard us with dire forecasts about our future.  We get a day in the market like Monday, August 8, 2011, and "Chicken Little" shows up everywhere to include radio, television,...